Roche Holding AG (RO) CHF1(Bearer)

Sell:300.00 CHFBuy:305.00 CHF4.60 CHF (1.54%)

Prices delayed by at least 15 minutes
Sell:300.00 CHF
Buy:305.00 CHF
Change:4.60 CHF (1.54%)
Deal now
Prices delayed by at least 15 minutes
Sell:300.00 CHF
Buy:305.00 CHF
Change:4.60 CHF (1.54%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Key people

Thomas Schinecker
Chief Executive Officer, Member of the Corporate Executive Committee
Alan Hippe
Member of the Corporate Executive Committee, Chief Financial and Information Officer
Cristina A. Wilbur
Member of the Corporate Executive Committee, Chief People Officer
Pascale Schmidt
Chief Compliance Officer
Claudia Boeckstiegel
Member of the Enlarged Corporate Executive Committee, General Counsel
Silke Hoernstein
Member of the Enlarged Corporate Executive Committee, Head Corporate Strategy and Sustainability, Secretary to the Corporate Executive Committee
Hans Clevers
Member of the Enlarged Corporate Executive Committee, Head Roche Pharma Research and Early Development (pRED)
Levi Garraway
Member of the Enlarged Corporate Committee, Head of Global Product Development and Chief Medical Officer
Teresa Graham
Member of the Corporate Executive Committee, Chief Executive Officer of Roche Pharmaceuticals
Aviv Regev
Member of the Enlarged Corporate Executive Committee, Head Genentech Research and Early Development (gRED)
Severin Anton Schwan
Non-Executive Chairman of the Board
Andre S. Hoffmann
Non-Executive Independent Vice Chairman of the Board
Joerg Duschmale
Non-Executive Independent Director
Patrick Frost
Non-Executive Independent Director
Anita Hauser
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CH0012032113
  • Market cap
    CHF 229.22bn
  • Employees
    103,605
  • Shares in issue
    702.56m
  • Exchange
    SIX Swiss Exchange
  • Index
    Swiss Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.